Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Depression 2Radiation Injuries 1Neoplasms 1Head and Neck Neoplasms 1Depressive Disorder, Major 1

Interventions

Radiotherapy 5Radiotherapy, Intensity-Modulated 4Cisplatin 2Amifostine 2endostar protein 1Vortioxetine 1Tooth Extraction 1Surveys and Questionnaires 1Steroids 1S 1 (combination) 1Radiotherapy, Conformal 1Radiation Dose Hypofractionation 1Patient Reported Outcome Measures 1Palonosetron 1Paclitaxel 1Olanzapine 1Neuropsychological Tests 1Mental Status and Dementia Tests 1Mass Screening 1Magnetic Resonance Spectroscopy 1Hyperbaric Oxygenation 1Heart Rate 1Fluorouracil 1Etoposide 1Echocardiography 1Diagnosis 1Dexamethasone 1Chemotherapy, Adjuvant 1Carboplatin 1Blood Specimen Collection 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Radiation Injuries × Vortioxetine × Clear all
NCT04818099 2021-03-26

Vortioxetine in the Treatment of Depression Associated With Head and Neck Cancers Undergoing Radiotherapy

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Phase 3 Unknown
208 enrolled
Head & Neck

Depression, Head and Neck Neoplasms, Radiation Injuries

Data powered by HemOnc (CC BY 4.0) Colophon âš¡